M&A Deal Summary |
|
|---|---|
| Date | 2012-10-04 |
| Target | LigoCyte Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Takeda |
| Sellers(s) | Eight Roads |
| Deal Type | Add-on Acquisition |
| Deal Value | 60M USD |
| Advisor(s) | Sagent Advisors LLC (Financial) Cooley (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1781 |
| Sector | Life Science |
| Employees | 47,347 |
| Revenue | 4.03T JPY (2023) |
Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was originally established in 1781 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 18 |
| Sector (Life Science) | 6 of 17 |
| Type (Add-on Acquisition) | 6 of 15 |
| State (Montana) | 1 of 1 |
| Country (United States) | 4 of 12 |
| Year (2012) | 1 of 2 |
| Size (of disclosed) | 8 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-12-21 |
Intellikine
La Jolla, California, United States Intellikine, Inc. is a private company focused on the development of innovative, small molecule drugs targeting the PI3K/mTOR pathway for the treatment of cancer and other serious diseases. |
Buy | $190M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-11-06 |
Envoy Therapeutics
Jupiter, Florida, United States Envoy Therapeutics, Inc. is a privately-held drug discovery company focused on finding new drugs with superior efficacy and fewer side effects than existing treatments. |
Buy | $140M |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 98 |
| Sector (Life Science) | 7 of 49 |
| Type (Add-on Acquisition) | 6 of 45 |
| State (Montana) | 1 of 1 |
| Country (United States) | 5 of 60 |
| Year (2012) | 2 of 3 |
| Size (of disclosed) | 18 of 19 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-04 |
Aclaris
Wayne, Pennsylvania, United States Aclaris is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris was founded in 2012 and is based in Wayne, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-22 |
NextWave Pharmaceuticals
Cupertino, California, United States NextWave Pharmaceuticals is a specialty pharmaceutical company developing extended release OTC and prescription products for children and adults. NextWave Pharmaceuticals was founded in 2005 and is based in Cupertino, California. |
Sell | $700M |
